Article Text

other Versions

PDF
High frequency of submicroscopic genomic aberrations detected by tiling path array CGH in patients with isolated congenital heart disease
  1. Fikret Erdogan (erdogan{at}molgen.mpg.de)
  1. Max Planck Institute for Molecular Genetics, Germany
    1. Lars Allen Larsen (lal{at}imbg.ku.dk)
    1. Wilhelm Johannsen Centre for Functional Genome Research, Denmark
      1. Litu Zhang (zhanglitu{at}gmail.com)
      1. Wilhelm Johannsen Centre for Functional Genome Research, Denmark
        1. Zeynep Tumer (zeynep{at}imbg.ku.dk)
        1. Panum Institute, Denmark
          1. Niels Tommerup (tommerup{at}imbg.ku.dk)
          1. Department of Molecular and Cellular Medicine, Denmark
            1. Wei Chen (wei{at}molgen.mpg.de)
            1. Max Planck Institute for Molecular Genetics, Germany
              1. Joes R Jacobsen
              1. Paediatric Cardiology, Rigshospitalet Copenhagen, Denmark
                1. Marei Schubert (schubert{at}molgen.mpg.de)
                1. Max Planck Institute for Molecular Genetics, Germany
                  1. Jan Jurkatis (janjurkatis{at}gmx.de)
                  1. Max Planck Institute for Molecular Genetics, Germany
                    1. Andreas Tzschach (tzschach{at}molgen.mpg.de)
                    1. Max Planck Institute for Molecular Genetics, Germany
                      1. Hilger H Ropers (ropers{at}molgen.mpg.de)
                      1. Max Planck Institute for Molecular Genetics, Germany
                        1. Reinhard Ullmann (ullmann{at}molgen.mpg.de)
                        1. Max Planck Institute for Molecular Genetics, Germany

                          Abstract

                          Background: Congenital heart disease (CHD) is the most frequent birth defect and affects nearly 1% of newborns. The etiology of CHD is largely unknown and only a small percentage can be assigned to environmental risk factors such as maternal diseases or exposure to mutagenic agents during pregnancy. Chromosomal imbalances have been identified in many forms of syndromic CHD, but next to nothing is known about the impact of DNA copy number changes in non-syndromic CHD.

                          Methods and Results: Here we present a sub-megabase resolution array CGH screen of 105 patients with CHD as the sole abnormality at the time of diagnosis. We have detected 18 chromosomal changes that do not coincide with frequent DNA copy number variants, including one de novo deletion, two de novo duplications and eight familial copy number variations; one deletion and seven duplications.

                          Conclusions: Our data show that sub-microscopic deletions and duplications play an important role in the aetiology of this condition, either as direct causes or as genetic risk factors for CHD. These findings have immediate consequences for genetic counseling and should pave the way for the elucidation of pathogenetic mechanisms underlying CHD.

                          Statistics from Altmetric.com

                          Request permissions

                          If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.